London
· Delayed Price · Currency is GBP · Price in USD Neurocrine Biosciences Statistics
Total Valuation
LON:0K6R has a market cap or net worth of GBP 7.93 billion. The enterprise value is 7.50 billion.
| Market Cap | 7.93B |
| Enterprise Value | 7.50B |
Important Dates
The next estimated earnings date is Friday, May 2, 2025.
| Earnings Date | May 2, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +2.67% |
| Shares Change (QoQ) | -1.34% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 97.75M |
Valuation Ratios
The trailing PE ratio is 29.10.
| PE Ratio | 29.10 |
| Forward PE | n/a |
| PS Ratio | 4.22 |
| PB Ratio | 3.84 |
| P/TBV Ratio | 3.90 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.31, with an EV/FCF ratio of 16.85.
| EV / Earnings | 27.50 |
| EV / Sales | 4.24 |
| EV / EBITDA | 15.31 |
| EV / EBIT | 17.12 |
| EV / FCF | 16.85 |
Financial Position
The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.40 |
| Quick Ratio | 3.06 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 0.76 |
| Debt / FCF | 0.89 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.16% and return on invested capital (ROIC) is 12.68%.
| Return on Equity (ROE) | 14.16% |
| Return on Assets (ROA) | 10.46% |
| Return on Invested Capital (ROIC) | 12.68% |
| Return on Capital Employed (ROCE) | 18.16% |
| Revenue Per Employee | 1.05M |
| Profits Per Employee | 151,456 |
| Employee Count | 1,800 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 15.99 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -23.32% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -23.32% |
| 50-Day Moving Average | 108.62 |
| 200-Day Moving Average | 126.47 |
| Relative Strength Index (RSI) | 54.97 |
| Average Volume (20 Days) | 1,062 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 2.79 |
Income Statement
In the last 12 months, LON:0K6R had revenue of GBP 1.88 billion and earned 272.62 million in profits. Earnings per share was 2.63.
| Revenue | 1.88B |
| Gross Profit | 1.27B |
| Operating Income | 465.68M |
| Pretax Income | 388.20M |
| Net Income | 272.62M |
| EBITDA | 487.33M |
| EBIT | 465.68M |
| Earnings Per Share (EPS) | 2.63 |
Balance Sheet
The company has 859.56 million in cash and 395.95 million in debt, giving a net cash position of 463.61 million.
| Cash & Cash Equivalents | 859.56M |
| Total Debt | 395.95M |
| Net Cash | 463.61M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.07B |
| Book Value Per Share | 20.81 |
| Working Capital | 972.10M |
Cash Flow
In the last 12 months, operating cash flow was 475.59 million and capital expenditures -30.51 million, giving a free cash flow of 445.07 million.
| Operating Cash Flow | 475.59M |
| Capital Expenditures | -30.51M |
| Free Cash Flow | 445.07M |
| FCF Per Share | n/a |
Margins
Gross margin is 67.52%, with operating and profit margins of 24.75% and 14.49%.
| Gross Margin | 67.52% |
| Operating Margin | 24.75% |
| Pretax Margin | 20.63% |
| Profit Margin | 14.49% |
| EBITDA Margin | 25.90% |
| EBIT Margin | 24.75% |
| FCF Margin | 23.66% |
Dividends & Yields
LON:0K6R does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.67% |
| Shareholder Yield | -2.67% |
| Earnings Yield | 3.44% |
| FCF Yield | 5.61% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
LON:0K6R has an Altman Z-Score of 8.68.
| Altman Z-Score | 8.68 |
| Piotroski F-Score | n/a |